Tcr2 Therapeutics Inc (TCRR) Ownership

1.48 ↑0.00 (0.00%)
As of Market Close on May 31st, 2023.

Institutional Ownership

Mpm Asset Management, LLC is the biggest individual institutional holder of Tcr2 Therapeutics Inc (TCRR), owning a total of 4.1 million shares. Combined, the top 25 institutional holders of TCRR own 58.50% of the company with a total of 22.9 million shares.

In the latest ownership report on March 31st 2023, the top 25 institutional holders increased their combined ownership of TCRR by 695 thousand shares. 3 institutions bought 1,055,125 total additional shares and increased their ownership by an average of 8.91%. However 3 institutions sold 360,433 total shares and decreased their ownership by an average of 21.45%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Tcr2 Therapeutics increased by a net total of 694,692 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Mpm Asset Management, LLC10.322%0.000%4,050,86502023-03-31
TANG CAPITAL MANAGEMENT LLC8.663%24.126%3,399,745660,7982023-03-31
MPM Oncology Impact Management LP8.590%0.000%3,370,98202023-03-31
Vanguard Group Inc3.743%2.617%1,468,80237,4562023-03-31
Baker Bros Advisors LP1.919%0.000%753,06402023-03-31
Artal Group S A1.911%0.000%750,00002023-03-31
Redmile Group, LLC1.678%-9.987%658,336-73,0432023-03-31
Renaissance Technologies Corp1.133%-35.842%444,800-248,4862023-03-31
Long Focus Capital Management, LLC0.909%0.000%356,871356,8712023-03-31
Bridgeway Capital Management, LLC0.463%0.000%181,81002023-03-31
Dimensional Fund Advisors, Inc.0.436%-18.515%171,214-38,9042023-03-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Mpm Asset Management, LLC10.322%0.000%4,050,86502023-03-31
TANG CAPITAL MANAGEMENT LLC8.663%24.126%3,399,745660,7982023-03-31
MPM Oncology Impact Management LP8.590%0.000%3,370,98202023-03-31
K2 PRINCIPAL FUND LP4.915%76.225%1,899,824821,7542022-09-30
Vanguard Group Inc3.743%2.617%1,468,80237,4562023-03-31
Newtyn Management LLC2.739%79.167%1,075,000475,0002022-12-31
Acadian Asset Management LLC2.229%28.068%874,853191,7392022-12-31
BlackRock Inc2.015%-22.895%790,873-234,8392022-12-31
Baker Bros Advisors LP1.919%0.000%753,06402023-03-31
Artal Group S A1.911%0.000%750,00002023-03-31
Redmile Group, LLC1.678%-9.987%658,336-73,0432023-03-31
JPMorgan Chase & Co1.336%-0.298%524,184-1,5642022-12-31
Citigroup Inc1.207%103,056.000%473,484473,0252022-12-31
Renaissance Technologies Corp1.133%-35.842%444,800-248,4862023-03-31
Long Focus Capital Management, LLC0.909%0.000%356,871356,8712023-03-31
Geode Capital Management, LLC0.804%-0.245%315,377-7732022-12-31
ArrowMark Colorado Holdings, LLC (ArrowMark Partne0.672%0.000%259,67202022-09-30
Two Sigma Advisers, LLC0.636%-36.733%249,653-144,9472022-12-31
Citadel Advisors Llc0.596%21.713%233,87641,7232022-12-31
Oasis Management Co. Ltd0.510%0.000%200,00002022-12-31
Bridgeway Capital Management, LLC0.463%0.000%181,81002023-03-31
Dimensional Fund Advisors, Inc.0.436%-18.515%171,214-38,9042023-03-31
D. E. Shaw & Co LP0.402%-73.139%155,495-423,3922022-09-30
Millennium Management LLC0.357%-47.771%140,041-128,0892022-12-31
Two Sigma Investments LLC0.312%-58.611%120,677-170,8912022-12-31

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Tcr2 Therapeutics Inc (TCRR), owning a total of 1 million shares. Combined, the top 27 mutual fund holders of TCRR own 12.52% of the company with a total of 4.9 million shares.

In the latest ownership report on April 30th 2023, the top 27 fund holders not made any changes to their ownership of TCRR. None of the mutual funds bought any additional shares.

Overall this is a neutral sign as the number of shares owned by the top 20 mutual funds holding Tcr2 Therapeutics stayed the same in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.500%0.000%981,01602023-04-30
Vanguard Extended Market Index Investor1.215%0.000%476,93402023-04-30

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.500%0.000%981,01602023-04-30
Vanguard Instl Ttl Stck Mkt Idx Tr2.500%0.000%981,01602023-03-31
JPM Thematics Genetic Thrps C2 Acc USD1.333%0.000%523,16702023-03-31
Vanguard Extended Market Index Investor1.215%0.000%476,93402023-04-30
iShares Biotechnology ETF0.702%-0.153%271,257-4162022-11-30
Fidelity® Extended Market Index0.473%0.000%185,77802023-03-31
Bridgeway Ultra-Small Company Market0.463%22.514%181,81033,4102023-03-31
AlphaCentric LifeSci Healthcare I0.391%0.000%151,00002022-09-30
iShares U.S. Small-Cap Eq Fac ETF0.308%0.000%120,862120,8622023-02-28
iShares MSCI USA Small-Cap Eq Fac ETF0.313%0.000%120,862120,8622023-02-28
Kennedy Micro Cap0.307%-0.185%120,408-2232022-09-30
Greenwich Ivy Long-Short Instl0.183%0.000%71,61671,6162022-12-31
USAA Small Cap Stock0.180%-1.558%70,792-1,1202022-12-31
iShares Micro-Cap ETF0.171%0.000%67,26902023-04-28
Fidelity® Small Cap Enhanced Index0.168%0.000%66,03302023-02-28
BlackRock Extended Mkt Composite0.168%0.000%65,78102023-03-31
BlackRock Extended Equity Market K0.145%-1.153%56,989-6652023-03-31
Harbor Disruptive Innovation Instl0.131%-18.297%51,568-11,5482023-03-31
T. Rowe Price Extended Equity Market Idx0.125%0.000%48,90002023-03-31
Fidelity® Total Market Index0.103%0.000%40,48702023-03-31
Fidelity® Series Total Market Index0.097%0.000%37,94102023-03-31
Blackrock Russell 2000 Alpha Tilts Fd A0.094%-0.070%37,053-262023-03-31
Fidelity® VIP Disciplined Small Cap Init0.092%0.000%36,07602023-02-28
iShares Core S&P Total US Stock Mkt ETF0.092%0.000%36,05402023-04-28
DFA US Targeted Value I0.089%0.000%34,71502023-03-31
CornerCap Fundametrics Small0.088%0.000%34,64902023-03-31
CornerCap Small-Cap Value Advisor0.088%0.000%34,64902022-12-31

Discussions

Please log in or register to share your thoughts.